RecruitingNot ApplicableNCT05183230

WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt


Sponsor

Weill Medical College of Cornell University

Enrollment

115 participants

Start Date

Apr 22, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e., cognitive reappraisal ability, and reduces suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).


Eligibility

Min Age: 50 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a smartphone-based app and coaching program (WellPATH-PREVENT) to help middle-aged and older adults stay safe and connected after being hospitalized for suicidal thoughts or a suicide attempt. **You may be eligible if:** - You are between 50 and 90 years old - You were recently hospitalized because of suicidal thoughts or a suicide attempt - You have a DSM-5 psychiatric diagnosis (but not a current psychotic disorder or dementia) - You are cognitively intact enough to use the app (MMSE score above 24) - You may be on psychiatric medications or in community therapy **You may NOT be eligible if:** - You have a current diagnosis of a psychotic disorder - You have been diagnosed with dementia - Your cognitive impairment is significant (MMSE score 24 or below) - You have a serious acute medical condition (such as delirium, severe organ failure, or a recent stroke or heart attack) - You have aphasia or severe sensory problems - You cannot speak English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALWellPATH-PREVENT

WellPATH-PREVENT is a novel personalized, easy to use, mainly stand-alone mobile intervention which focuses on the exclusive use of the WellPATH tablet app and includes training meetings during hospitalization, and virtual post-discharge coaching meetings. The meetings aim to: a) identify stressors and triggers of negative emotions associated with increased suicidal ideation or with suicidal behavior; b) develop techniques (text or video) to increase cognitive reappraisal ability; c) incorporate the techniques into the WellPATH app and promote the use of WellPATH during stressful incidents, triggers of negative emotions, or scheduled brief training sessions; and d) remotely update the triggers, negative emotions, and techniques in the app.

BEHAVIORALOptimized WellPATH-PREVENT

The Optimized WellPATH-PREVENT intervention will be as described above, but based on the results of the Proof-of-Concept (R61) Phase, an expert committee will help select the duration (6 or 12 weeks) that shows greater improvement in cognitive reappraisal.


Locations(2)

New York Presbyterian Hospital/Weill Cornell Medicine

New York, New York, United States

Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine

White Plains, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05183230


Related Trials